Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.28+0.03 (+2.40%)
Close on Nov 17, 2026Market cap $97.53MP/E –Yield –
Neuronetics total assets
Total assets on the balance sheet at the end of each period.
Neuronetics's total assets was $131.53M at Jun 30, 2026. For fiscal 2025 it was $141.55M, up 0.5% from the year before. The highest annual figure on record is $141.55M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.55M | +0.5% |
| FY2024 | Dec 31, 2024 | $140.90M | +21.6% |
| FY2023 | Dec 31, 2023 | $115.83M | -0.9% |
| FY2022 | Dec 31, 2022 | $116.88M | -17.2% |
| FY2021 | Dec 31, 2021 | $141.22M | +79.5% |
| FY2020 | Dec 31, 2020 | $78.66M | -21.5% |
| FY2019 | Dec 31, 2019 | $100.17M | -14.4% |
| FY2018 | Dec 31, 2018 | $117.02M | +200.5% |
| FY2017 | Dec 31, 2017 | $38.94M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $131.53M | -2.3% |
| Q1 FY2026 | Mar 31, 2026 | $125.44M | -11.7% |
| Q4 FY2025 | Dec 31, 2025 | $141.55M | +0.5% |
| Q3 FY2025 | Sep 30, 2025 | $145.47M | +96.3% |
| Q2 FY2025 | Jun 30, 2025 | $134.65M | +39.1% |
| Q1 FY2025 | Mar 31, 2025 | $141.99M | +36.8% |
| Q4 FY2024 | Dec 31, 2024 | $140.90M | +21.6% |
| Q3 FY2024 | Sep 30, 2024 | $74.12M | -20.3% |
| Q2 FY2024 | Jun 30, 2024 | $96.81M | -3.6% |
| Q1 FY2024 | Mar 31, 2024 | $103.81M | +0.2% |
| Q4 FY2023 | Dec 31, 2023 | $115.83M | -0.9% |
| Q3 FY2023 | Sep 30, 2023 | $92.99M | -22.0% |
| Q2 FY2023 | Jun 30, 2023 | $100.39M | -18.3% |
| Q1 FY2023 | Mar 31, 2023 | $103.60M | -20.3% |
| Q4 FY2022 | Dec 31, 2022 | $116.88M | -17.2% |
| Q3 FY2022 | Sep 30, 2022 | $119.24M | -16.7% |
| Q2 FY2022 | Jun 30, 2022 | $122.95M | -17.0% |
| Q1 FY2022 | Mar 31, 2022 | $129.94M | -14.7% |
| Q4 FY2021 | Dec 31, 2021 | $141.22M | +79.5% |
| Q3 FY2021 | Sep 30, 2021 | $143.07M | +82.6% |
| Q2 FY2021 | Jun 30, 2021 | $148.10M | +85.1% |
| Q1 FY2021 | Mar 31, 2021 | $152.31M | +72.2% |
| Q4 FY2020 | Dec 31, 2020 | $78.66M | -21.5% |
| Q3 FY2020 | Sep 30, 2020 | $78.34M | -25.7% |
| Q2 FY2020 | Jun 30, 2020 | $79.99M | -26.9% |
| Q1 FY2020 | Mar 31, 2020 | $88.46M | -22.0% |
| Q4 FY2019 | Dec 31, 2019 | $100.17M | -14.4% |
| Q3 FY2019 | Sep 30, 2019 | $105.48M | -11.3% |
| Q2 FY2019 | Jun 30, 2019 | $109.43M | +286.1% |
| Q1 FY2019 | Mar 31, 2019 | $113.44M | +191.3% |
| Q4 FY2018 | Dec 31, 2018 | $117.02M | – |
| Q3 FY2018 | Sep 30, 2018 | $118.98M | – |
| Q2 FY2018 | Jun 30, 2018 | $28.35M | – |
| Q4 FY2017 | Dec 31, 2017 | $38.94M | – |
See a number that looks wrong?